nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranitidine—SLC22A1—Cladribine—multiple sclerosis	0.153	0.205	CbGbCtD
Ranitidine—CYP2D6—Fingolimod—multiple sclerosis	0.0685	0.0916	CbGbCtD
Ranitidine—ABCB1—Methylprednisolone—multiple sclerosis	0.0469	0.0627	CbGbCtD
Ranitidine—SLC22A8—Methotrexate—multiple sclerosis	0.0459	0.0614	CbGbCtD
Ranitidine—CYP3A4—Fingolimod—multiple sclerosis	0.0436	0.0583	CbGbCtD
Ranitidine—CYP2C19—Prednisone—multiple sclerosis	0.0352	0.0471	CbGbCtD
Ranitidine—ABCB1—Mitoxantrone—multiple sclerosis	0.0342	0.0457	CbGbCtD
Ranitidine—ABCB1—Betamethasone—multiple sclerosis	0.0305	0.0408	CbGbCtD
Ranitidine—ABCB1—Prednisolone—multiple sclerosis	0.0301	0.0402	CbGbCtD
Ranitidine—ABCB1—Prednisone—multiple sclerosis	0.0284	0.038	CbGbCtD
Ranitidine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0281	0.0375	CbGbCtD
Ranitidine—CYP3A5—Dexamethasone—multiple sclerosis	0.0272	0.0364	CbGbCtD
Ranitidine—CYP2C19—Dexamethasone—multiple sclerosis	0.022	0.0294	CbGbCtD
Ranitidine—CYP3A4—Triamcinolone—multiple sclerosis	0.0213	0.0285	CbGbCtD
Ranitidine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0205	0.0274	CbGbCtD
Ranitidine—CYP3A4—Betamethasone—multiple sclerosis	0.0183	0.0244	CbGbCtD
Ranitidine—CYP3A4—Prednisolone—multiple sclerosis	0.018	0.0241	CbGbCtD
Ranitidine—ABCB1—Dexamethasone—multiple sclerosis	0.0177	0.0237	CbGbCtD
Ranitidine—CYP3A4—Prednisone—multiple sclerosis	0.017	0.0227	CbGbCtD
Ranitidine—CYP2D6—Dexamethasone—multiple sclerosis	0.0167	0.0223	CbGbCtD
Ranitidine—ABCB1—Methotrexate—multiple sclerosis	0.0142	0.019	CbGbCtD
Ranitidine—CYP3A4—Dexamethasone—multiple sclerosis	0.0106	0.0142	CbGbCtD
Ranitidine—Nizatidine—BCHE—multiple sclerosis	0.00899	1	CrCbGaD
Ranitidine—Abdominal pain—Azathioprine—multiple sclerosis	0.000379	0.00179	CcSEcCtD
Ranitidine—Tachycardia—Mitoxantrone—multiple sclerosis	0.000378	0.00179	CcSEcCtD
Ranitidine—Vomiting—Cladribine—multiple sclerosis	0.000375	0.00177	CcSEcCtD
Ranitidine—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000375	0.00177	CcSEcCtD
Ranitidine—Erectile dysfunction—Prednisone—multiple sclerosis	0.000374	0.00177	CcSEcCtD
Ranitidine—Rash—Cladribine—multiple sclerosis	0.000372	0.00176	CcSEcCtD
Ranitidine—Hallucination—Dexamethasone—multiple sclerosis	0.000372	0.00176	CcSEcCtD
Ranitidine—Hallucination—Betamethasone—multiple sclerosis	0.000372	0.00176	CcSEcCtD
Ranitidine—Dermatitis—Cladribine—multiple sclerosis	0.000371	0.00176	CcSEcCtD
Ranitidine—Headache—Cladribine—multiple sclerosis	0.000369	0.00175	CcSEcCtD
Ranitidine—Arrhythmia—Triamcinolone—multiple sclerosis	0.000368	0.00174	CcSEcCtD
Ranitidine—Weight decreased—Prednisone—multiple sclerosis	0.000368	0.00174	CcSEcCtD
Ranitidine—Vision blurred—Prednisolone—multiple sclerosis	0.000367	0.00174	CcSEcCtD
Ranitidine—Arrhythmia—Methylprednisolone—multiple sclerosis	0.000367	0.00173	CcSEcCtD
Ranitidine—Hypotension—Mitoxantrone—multiple sclerosis	0.000362	0.00171	CcSEcCtD
Ranitidine—Ill-defined disorder—Prednisolone—multiple sclerosis	0.000362	0.00171	CcSEcCtD
Ranitidine—Erythema—Triamcinolone—multiple sclerosis	0.000358	0.00169	CcSEcCtD
Ranitidine—Erythema—Methylprednisolone—multiple sclerosis	0.000358	0.00169	CcSEcCtD
Ranitidine—Angioedema—Prednisolone—multiple sclerosis	0.000356	0.00168	CcSEcCtD
Ranitidine—Breast disorder—Methotrexate—multiple sclerosis	0.000355	0.00168	CcSEcCtD
Ranitidine—Hypersensitivity—Azathioprine—multiple sclerosis	0.000353	0.00167	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000353	0.00167	CcSEcCtD
Ranitidine—Malaise—Prednisolone—multiple sclerosis	0.000351	0.00166	CcSEcCtD
Ranitidine—Nausea—Cladribine—multiple sclerosis	0.00035	0.00166	CcSEcCtD
Ranitidine—Vertigo—Prednisolone—multiple sclerosis	0.00035	0.00165	CcSEcCtD
Ranitidine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000346	0.00163	CcSEcCtD
Ranitidine—Somnolence—Mitoxantrone—multiple sclerosis	0.000345	0.00163	CcSEcCtD
Ranitidine—Eosinophilia—Methotrexate—multiple sclerosis	0.000336	0.00159	CcSEcCtD
Ranitidine—Arrhythmia—Dexamethasone—multiple sclerosis	0.000334	0.00158	CcSEcCtD
Ranitidine—Arrhythmia—Betamethasone—multiple sclerosis	0.000334	0.00158	CcSEcCtD
Ranitidine—Pancreatitis—Methotrexate—multiple sclerosis	0.000333	0.00157	CcSEcCtD
Ranitidine—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000332	0.00157	CcSEcCtD
Ranitidine—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000332	0.00157	CcSEcCtD
Ranitidine—Pain—Mitoxantrone—multiple sclerosis	0.000331	0.00157	CcSEcCtD
Ranitidine—Constipation—Mitoxantrone—multiple sclerosis	0.000331	0.00157	CcSEcCtD
Ranitidine—Bradycardia—Prednisone—multiple sclerosis	0.000331	0.00156	CcSEcCtD
Ranitidine—Alopecia—Betamethasone—multiple sclerosis	0.00033	0.00156	CcSEcCtD
Ranitidine—Alopecia—Dexamethasone—multiple sclerosis	0.00033	0.00156	CcSEcCtD
Ranitidine—Diarrhoea—Azathioprine—multiple sclerosis	0.000328	0.00155	CcSEcCtD
Ranitidine—Discomfort—Prednisolone—multiple sclerosis	0.000328	0.00155	CcSEcCtD
Ranitidine—Angioedema—Triamcinolone—multiple sclerosis	0.000327	0.00155	CcSEcCtD
Ranitidine—Angioedema—Methylprednisolone—multiple sclerosis	0.000327	0.00154	CcSEcCtD
Ranitidine—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000326	0.00154	CcSEcCtD
Ranitidine—Erythema—Dexamethasone—multiple sclerosis	0.000325	0.00154	CcSEcCtD
Ranitidine—Erythema—Betamethasone—multiple sclerosis	0.000325	0.00154	CcSEcCtD
Ranitidine—Hallucination—Prednisone—multiple sclerosis	0.000324	0.00153	CcSEcCtD
Ranitidine—Malaise—Triamcinolone—multiple sclerosis	0.000323	0.00153	CcSEcCtD
Ranitidine—Pancytopenia—Methotrexate—multiple sclerosis	0.000323	0.00152	CcSEcCtD
Ranitidine—Malaise—Methylprednisolone—multiple sclerosis	0.000322	0.00152	CcSEcCtD
Ranitidine—Vertigo—Triamcinolone—multiple sclerosis	0.000322	0.00152	CcSEcCtD
Ranitidine—Vertigo—Methylprednisolone—multiple sclerosis	0.000321	0.00152	CcSEcCtD
Ranitidine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000319	0.00151	CcSEcCtD
Ranitidine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000318	0.0015	CcSEcCtD
Ranitidine—Neutropenia—Methotrexate—multiple sclerosis	0.000318	0.0015	CcSEcCtD
Ranitidine—Dizziness—Azathioprine—multiple sclerosis	0.000317	0.0015	CcSEcCtD
Ranitidine—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000313	0.00148	CcSEcCtD
Ranitidine—Tachycardia—Prednisolone—multiple sclerosis	0.00031	0.00147	CcSEcCtD
Ranitidine—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.00031	0.00147	CcSEcCtD
Ranitidine—Urticaria—Mitoxantrone—multiple sclerosis	0.000308	0.00146	CcSEcCtD
Ranitidine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000307	0.00145	CcSEcCtD
Ranitidine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000306	0.00145	CcSEcCtD
Ranitidine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000306	0.00145	CcSEcCtD
Ranitidine—Myalgia—Triamcinolone—multiple sclerosis	0.000305	0.00144	CcSEcCtD
Ranitidine—Vomiting—Azathioprine—multiple sclerosis	0.000305	0.00144	CcSEcCtD
Ranitidine—Pneumonia—Methotrexate—multiple sclerosis	0.000305	0.00144	CcSEcCtD
Ranitidine—Arthralgia—Methylprednisolone—multiple sclerosis	0.000304	0.00144	CcSEcCtD
Ranitidine—Myalgia—Methylprednisolone—multiple sclerosis	0.000304	0.00144	CcSEcCtD
Ranitidine—Rash—Azathioprine—multiple sclerosis	0.000302	0.00143	CcSEcCtD
Ranitidine—Dermatitis—Azathioprine—multiple sclerosis	0.000302	0.00143	CcSEcCtD
Ranitidine—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000302	0.00143	CcSEcCtD
Ranitidine—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000302	0.00143	CcSEcCtD
Ranitidine—Discomfort—Triamcinolone—multiple sclerosis	0.000301	0.00142	CcSEcCtD
Ranitidine—Discomfort—Methylprednisolone—multiple sclerosis	0.000301	0.00142	CcSEcCtD
Ranitidine—Headache—Azathioprine—multiple sclerosis	0.0003	0.00142	CcSEcCtD
Ranitidine—Angioedema—Dexamethasone—multiple sclerosis	0.000297	0.0014	CcSEcCtD
Ranitidine—Angioedema—Betamethasone—multiple sclerosis	0.000297	0.0014	CcSEcCtD
Ranitidine—Confusional state—Methylprednisolone—multiple sclerosis	0.000294	0.00139	CcSEcCtD
Ranitidine—Malaise—Dexamethasone—multiple sclerosis	0.000293	0.00139	CcSEcCtD
Ranitidine—Malaise—Betamethasone—multiple sclerosis	0.000293	0.00139	CcSEcCtD
Ranitidine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000292	0.00138	CcSEcCtD
Ranitidine—Vertigo—Betamethasone—multiple sclerosis	0.000292	0.00138	CcSEcCtD
Ranitidine—Vertigo—Dexamethasone—multiple sclerosis	0.000292	0.00138	CcSEcCtD
Ranitidine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000292	0.00138	CcSEcCtD
Ranitidine—Arrhythmia—Prednisone—multiple sclerosis	0.000291	0.00137	CcSEcCtD
Ranitidine—Sweating—Methotrexate—multiple sclerosis	0.00029	0.00137	CcSEcCtD
Ranitidine—Insomnia—Prednisolone—multiple sclerosis	0.000288	0.00136	CcSEcCtD
Ranitidine—Alopecia—Prednisone—multiple sclerosis	0.000287	0.00136	CcSEcCtD
Ranitidine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000286	0.00135	CcSEcCtD
Ranitidine—Tachycardia—Triamcinolone—multiple sclerosis	0.000285	0.00135	CcSEcCtD
Ranitidine—Nausea—Azathioprine—multiple sclerosis	0.000285	0.00135	CcSEcCtD
Ranitidine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000285	0.00135	CcSEcCtD
Ranitidine—Erythema—Prednisone—multiple sclerosis	0.000283	0.00134	CcSEcCtD
Ranitidine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000283	0.00134	CcSEcCtD
Ranitidine—Agranulocytosis—Methotrexate—multiple sclerosis	0.000283	0.00134	CcSEcCtD
Ranitidine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000282	0.00133	CcSEcCtD
Ranitidine—Myalgia—Dexamethasone—multiple sclerosis	0.000277	0.00131	CcSEcCtD
Ranitidine—Myalgia—Betamethasone—multiple sclerosis	0.000277	0.00131	CcSEcCtD
Ranitidine—Discomfort—Dexamethasone—multiple sclerosis	0.000273	0.00129	CcSEcCtD
Ranitidine—Discomfort—Betamethasone—multiple sclerosis	0.000273	0.00129	CcSEcCtD
Ranitidine—Hypotension—Methylprednisolone—multiple sclerosis	0.000273	0.00129	CcSEcCtD
Ranitidine—Pain—Prednisolone—multiple sclerosis	0.000272	0.00129	CcSEcCtD
Ranitidine—Hepatitis—Methotrexate—multiple sclerosis	0.000272	0.00128	CcSEcCtD
Ranitidine—Vision blurred—Prednisone—multiple sclerosis	0.000267	0.00126	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000266	0.00126	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000266	0.00126	CcSEcCtD
Ranitidine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000265	0.00125	CcSEcCtD
Ranitidine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000265	0.00125	CcSEcCtD
Ranitidine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000265	0.00125	CcSEcCtD
Ranitidine—Insomnia—Triamcinolone—multiple sclerosis	0.000264	0.00125	CcSEcCtD
Ranitidine—Insomnia—Methylprednisolone—multiple sclerosis	0.000264	0.00125	CcSEcCtD
Ranitidine—Ill-defined disorder—Prednisone—multiple sclerosis	0.000263	0.00124	CcSEcCtD
Ranitidine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000262	0.00124	CcSEcCtD
Ranitidine—Anaemia—Prednisone—multiple sclerosis	0.000262	0.00124	CcSEcCtD
Ranitidine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000261	0.00123	CcSEcCtD
Ranitidine—Agitation—Prednisone—multiple sclerosis	0.00026	0.00123	CcSEcCtD
Ranitidine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.00026	0.00123	CcSEcCtD
Ranitidine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.00026	0.00123	CcSEcCtD
Ranitidine—Tachycardia—Dexamethasone—multiple sclerosis	0.000259	0.00122	CcSEcCtD
Ranitidine—Tachycardia—Betamethasone—multiple sclerosis	0.000259	0.00122	CcSEcCtD
Ranitidine—Angioedema—Prednisone—multiple sclerosis	0.000259	0.00122	CcSEcCtD
Ranitidine—Erythema multiforme—Methotrexate—multiple sclerosis	0.000257	0.00121	CcSEcCtD
Ranitidine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000257	0.00121	CcSEcCtD
Ranitidine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000257	0.00121	CcSEcCtD
Ranitidine—Malaise—Prednisone—multiple sclerosis	0.000255	0.00121	CcSEcCtD
Ranitidine—Vertigo—Prednisone—multiple sclerosis	0.000254	0.0012	CcSEcCtD
Ranitidine—Urticaria—Prednisolone—multiple sclerosis	0.000253	0.00119	CcSEcCtD
Ranitidine—Pain—Triamcinolone—multiple sclerosis	0.00025	0.00118	CcSEcCtD
Ranitidine—Hypotension—Betamethasone—multiple sclerosis	0.000248	0.00117	CcSEcCtD
Ranitidine—Hypotension—Dexamethasone—multiple sclerosis	0.000248	0.00117	CcSEcCtD
Ranitidine—Vomiting—Mitoxantrone—multiple sclerosis	0.000246	0.00116	CcSEcCtD
Ranitidine—Rash—Mitoxantrone—multiple sclerosis	0.000244	0.00116	CcSEcCtD
Ranitidine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000244	0.00115	CcSEcCtD
Ranitidine—Headache—Mitoxantrone—multiple sclerosis	0.000243	0.00115	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000242	0.00114	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000242	0.00114	CcSEcCtD
Ranitidine—Arthralgia—Prednisone—multiple sclerosis	0.000241	0.00114	CcSEcCtD
Ranitidine—Myalgia—Prednisone—multiple sclerosis	0.000241	0.00114	CcSEcCtD
Ranitidine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000241	0.00114	CcSEcCtD
Ranitidine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00024	0.00114	CcSEcCtD
Ranitidine—Alopecia—Methotrexate—multiple sclerosis	0.00024	0.00114	CcSEcCtD
Ranitidine—Insomnia—Betamethasone—multiple sclerosis	0.00024	0.00113	CcSEcCtD
Ranitidine—Insomnia—Dexamethasone—multiple sclerosis	0.00024	0.00113	CcSEcCtD
Ranitidine—Discomfort—Prednisone—multiple sclerosis	0.000238	0.00113	CcSEcCtD
Ranitidine—Erythema—Methotrexate—multiple sclerosis	0.000237	0.00112	CcSEcCtD
Ranitidine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000234	0.00111	CcSEcCtD
Ranitidine—Urticaria—Triamcinolone—multiple sclerosis	0.000232	0.0011	CcSEcCtD
Ranitidine—Urticaria—Methylprednisolone—multiple sclerosis	0.000232	0.0011	CcSEcCtD
Ranitidine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000231	0.00109	CcSEcCtD
Ranitidine—Anaphylactic shock—Prednisone—multiple sclerosis	0.000231	0.00109	CcSEcCtD
Ranitidine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000231	0.00109	CcSEcCtD
Ranitidine—Nausea—Mitoxantrone—multiple sclerosis	0.00023	0.00109	CcSEcCtD
Ranitidine—Pain—Dexamethasone—multiple sclerosis	0.000227	0.00107	CcSEcCtD
Ranitidine—Pain—Betamethasone—multiple sclerosis	0.000227	0.00107	CcSEcCtD
Ranitidine—Tachycardia—Prednisone—multiple sclerosis	0.000226	0.00107	CcSEcCtD
Ranitidine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000223	0.00106	CcSEcCtD
Ranitidine—Vision blurred—Methotrexate—multiple sclerosis	0.000223	0.00105	CcSEcCtD
Ranitidine—Ill-defined disorder—Methotrexate—multiple sclerosis	0.00022	0.00104	CcSEcCtD
Ranitidine—Anaemia—Methotrexate—multiple sclerosis	0.000219	0.00103	CcSEcCtD
Ranitidine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000219	0.00103	CcSEcCtD
Ranitidine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000219	0.00103	CcSEcCtD
Ranitidine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000215	0.00102	CcSEcCtD
Ranitidine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000215	0.00102	CcSEcCtD
Ranitidine—Malaise—Methotrexate—multiple sclerosis	0.000213	0.00101	CcSEcCtD
Ranitidine—Vertigo—Methotrexate—multiple sclerosis	0.000213	0.001	CcSEcCtD
Ranitidine—Leukopenia—Methotrexate—multiple sclerosis	0.000212	0.001	CcSEcCtD
Ranitidine—Urticaria—Dexamethasone—multiple sclerosis	0.000211	0.000996	CcSEcCtD
Ranitidine—Urticaria—Betamethasone—multiple sclerosis	0.000211	0.000996	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000211	0.000995	CcSEcCtD
Ranitidine—Dizziness—Prednisolone—multiple sclerosis	0.00021	0.000994	CcSEcCtD
Ranitidine—Abdominal pain—Betamethasone—multiple sclerosis	0.00021	0.000991	CcSEcCtD
Ranitidine—Body temperature increased—Betamethasone—multiple sclerosis	0.00021	0.000991	CcSEcCtD
Ranitidine—Body temperature increased—Dexamethasone—multiple sclerosis	0.00021	0.000991	CcSEcCtD
Ranitidine—Abdominal pain—Dexamethasone—multiple sclerosis	0.00021	0.000991	CcSEcCtD
Ranitidine—Insomnia—Prednisone—multiple sclerosis	0.000209	0.000988	CcSEcCtD
Ranitidine—Pruritus—Triamcinolone—multiple sclerosis	0.000207	0.000978	CcSEcCtD
Ranitidine—Pruritus—Methylprednisolone—multiple sclerosis	0.000206	0.000976	CcSEcCtD
Ranitidine—Chest pain—Methotrexate—multiple sclerosis	0.000201	0.000952	CcSEcCtD
Ranitidine—Arthralgia—Methotrexate—multiple sclerosis	0.000201	0.000952	CcSEcCtD
Ranitidine—Myalgia—Methotrexate—multiple sclerosis	0.000201	0.000952	CcSEcCtD
Ranitidine—Rash—Prednisolone—multiple sclerosis	0.0002	0.000948	CcSEcCtD
Ranitidine—Dermatitis—Prednisolone—multiple sclerosis	0.0002	0.000947	CcSEcCtD
Ranitidine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.0002	0.000944	CcSEcCtD
Ranitidine—Headache—Prednisolone—multiple sclerosis	0.000199	0.000942	CcSEcCtD
Ranitidine—Discomfort—Methotrexate—multiple sclerosis	0.000199	0.000941	CcSEcCtD
Ranitidine—Constipation—Prednisone—multiple sclerosis	0.000198	0.000934	CcSEcCtD
Ranitidine—Confusional state—Methotrexate—multiple sclerosis	0.000195	0.00092	CcSEcCtD
Ranitidine—Dizziness—Triamcinolone—multiple sclerosis	0.000193	0.000914	CcSEcCtD
Ranitidine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000193	0.000913	CcSEcCtD
Ranitidine—Dizziness—Methylprednisolone—multiple sclerosis	0.000193	0.000912	CcSEcCtD
Ranitidine—Feeling abnormal—Prednisone—multiple sclerosis	0.00019	0.0009	CcSEcCtD
Ranitidine—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000189	0.000894	CcSEcCtD
Ranitidine—Nausea—Prednisolone—multiple sclerosis	0.000189	0.000893	CcSEcCtD
Ranitidine—Pruritus—Dexamethasone—multiple sclerosis	0.000188	0.000887	CcSEcCtD
Ranitidine—Pruritus—Betamethasone—multiple sclerosis	0.000188	0.000887	CcSEcCtD
Ranitidine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000187	0.000882	CcSEcCtD
Ranitidine—Vomiting—Triamcinolone—multiple sclerosis	0.000186	0.000879	CcSEcCtD
Ranitidine—Vomiting—Methylprednisolone—multiple sclerosis	0.000186	0.000877	CcSEcCtD
Ranitidine—Rash—Triamcinolone—multiple sclerosis	0.000184	0.000871	CcSEcCtD
Ranitidine—Dermatitis—Triamcinolone—multiple sclerosis	0.000184	0.000871	CcSEcCtD
Ranitidine—Rash—Methylprednisolone—multiple sclerosis	0.000184	0.00087	CcSEcCtD
Ranitidine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000184	0.000869	CcSEcCtD
Ranitidine—Urticaria—Prednisone—multiple sclerosis	0.000184	0.000868	CcSEcCtD
Ranitidine—Headache—Triamcinolone—multiple sclerosis	0.000183	0.000866	CcSEcCtD
Ranitidine—Headache—Methylprednisolone—multiple sclerosis	0.000183	0.000864	CcSEcCtD
Ranitidine—Body temperature increased—Prednisone—multiple sclerosis	0.000183	0.000863	CcSEcCtD
Ranitidine—Abdominal pain—Prednisone—multiple sclerosis	0.000183	0.000863	CcSEcCtD
Ranitidine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000182	0.000858	CcSEcCtD
Ranitidine—Diarrhoea—Betamethasone—multiple sclerosis	0.000182	0.000858	CcSEcCtD
Ranitidine—Hypotension—Methotrexate—multiple sclerosis	0.00018	0.000853	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000176	0.000832	CcSEcCtD
Ranitidine—Dizziness—Betamethasone—multiple sclerosis	0.000175	0.000829	CcSEcCtD
Ranitidine—Dizziness—Dexamethasone—multiple sclerosis	0.000175	0.000829	CcSEcCtD
Ranitidine—Insomnia—Methotrexate—multiple sclerosis	0.000175	0.000826	CcSEcCtD
Ranitidine—Nausea—Triamcinolone—multiple sclerosis	0.000174	0.000821	CcSEcCtD
Ranitidine—Nausea—Methylprednisolone—multiple sclerosis	0.000173	0.000819	CcSEcCtD
Ranitidine—Dyspnoea—Methotrexate—multiple sclerosis	0.000172	0.000814	CcSEcCtD
Ranitidine—Somnolence—Methotrexate—multiple sclerosis	0.000172	0.000811	CcSEcCtD
Ranitidine—Hypersensitivity—Prednisone—multiple sclerosis	0.00017	0.000805	CcSEcCtD
Ranitidine—Vomiting—Betamethasone—multiple sclerosis	0.000169	0.000797	CcSEcCtD
Ranitidine—Vomiting—Dexamethasone—multiple sclerosis	0.000169	0.000797	CcSEcCtD
Ranitidine—Rash—Dexamethasone—multiple sclerosis	0.000167	0.000791	CcSEcCtD
Ranitidine—Rash—Betamethasone—multiple sclerosis	0.000167	0.000791	CcSEcCtD
Ranitidine—Dermatitis—Betamethasone—multiple sclerosis	0.000167	0.00079	CcSEcCtD
Ranitidine—Dermatitis—Dexamethasone—multiple sclerosis	0.000167	0.00079	CcSEcCtD
Ranitidine—Headache—Betamethasone—multiple sclerosis	0.000166	0.000786	CcSEcCtD
Ranitidine—Headache—Dexamethasone—multiple sclerosis	0.000166	0.000786	CcSEcCtD
Ranitidine—Pain—Methotrexate—multiple sclerosis	0.000165	0.000781	CcSEcCtD
Ranitidine—Pruritus—Prednisone—multiple sclerosis	0.000163	0.000773	CcSEcCtD
Ranitidine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000159	0.000752	CcSEcCtD
Ranitidine—Diarrhoea—Prednisone—multiple sclerosis	0.000158	0.000747	CcSEcCtD
Ranitidine—Nausea—Betamethasone—multiple sclerosis	0.000158	0.000745	CcSEcCtD
Ranitidine—Nausea—Dexamethasone—multiple sclerosis	0.000158	0.000745	CcSEcCtD
Ranitidine—Urticaria—Methotrexate—multiple sclerosis	0.000153	0.000725	CcSEcCtD
Ranitidine—Dizziness—Prednisone—multiple sclerosis	0.000153	0.000722	CcSEcCtD
Ranitidine—Abdominal pain—Methotrexate—multiple sclerosis	0.000153	0.000722	CcSEcCtD
Ranitidine—Body temperature increased—Methotrexate—multiple sclerosis	0.000153	0.000722	CcSEcCtD
Ranitidine—Vomiting—Prednisone—multiple sclerosis	0.000147	0.000694	CcSEcCtD
Ranitidine—Rash—Prednisone—multiple sclerosis	0.000146	0.000689	CcSEcCtD
Ranitidine—Dermatitis—Prednisone—multiple sclerosis	0.000146	0.000688	CcSEcCtD
Ranitidine—Headache—Prednisone—multiple sclerosis	0.000145	0.000684	CcSEcCtD
Ranitidine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000142	0.000672	CcSEcCtD
Ranitidine—Nausea—Prednisone—multiple sclerosis	0.000137	0.000649	CcSEcCtD
Ranitidine—Pruritus—Methotrexate—multiple sclerosis	0.000137	0.000646	CcSEcCtD
Ranitidine—Diarrhoea—Methotrexate—multiple sclerosis	0.000132	0.000625	CcSEcCtD
Ranitidine—Dizziness—Methotrexate—multiple sclerosis	0.000128	0.000604	CcSEcCtD
Ranitidine—Vomiting—Methotrexate—multiple sclerosis	0.000123	0.00058	CcSEcCtD
Ranitidine—Rash—Methotrexate—multiple sclerosis	0.000122	0.000576	CcSEcCtD
Ranitidine—Dermatitis—Methotrexate—multiple sclerosis	0.000122	0.000575	CcSEcCtD
Ranitidine—Headache—Methotrexate—multiple sclerosis	0.000121	0.000572	CcSEcCtD
Ranitidine—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000119	0.00374	CbGpPWpGaD
Ranitidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.000118	0.0037	CbGpPWpGaD
Ranitidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.000115	0.0036	CbGpPWpGaD
Ranitidine—Nausea—Methotrexate—multiple sclerosis	0.000115	0.000542	CcSEcCtD
Ranitidine—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000113	0.00354	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	0.000112	0.00351	CbGpPWpGaD
Ranitidine—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000111	0.00349	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—CD28—multiple sclerosis	0.000108	0.00341	CbGpPWpGaD
Ranitidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.000106	0.00333	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—S1PR1—multiple sclerosis	0.000104	0.00326	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	0.000104	0.00326	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	0.000103	0.00323	CbGpPWpGaD
Ranitidine—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.000102	0.00321	CbGpPWpGaD
Ranitidine—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.000102	0.00321	CbGpPWpGaD
Ranitidine—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000101	0.00316	CbGpPWpGaD
Ranitidine—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000101	0.00316	CbGpPWpGaD
Ranitidine—SLC22A8—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.0001	0.00315	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—CD40—multiple sclerosis	9.9e-05	0.00311	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	9.76e-05	0.00307	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—CCL3—multiple sclerosis	9.66e-05	0.00303	CbGpPWpGaD
Ranitidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	9.53e-05	0.00299	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—S1PR1—multiple sclerosis	9.44e-05	0.00296	CbGpPWpGaD
Ranitidine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	9.43e-05	0.00296	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—PTGER4—multiple sclerosis	9.3e-05	0.00292	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—CXCR3—multiple sclerosis	8.98e-05	0.00282	CbGpPWpGaD
Ranitidine—SLC22A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	8.93e-05	0.00281	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	8.92e-05	0.0028	CbGpPWpGaD
Ranitidine—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.86e-05	0.00278	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—RGS1—multiple sclerosis	8.84e-05	0.00278	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—CCR2—multiple sclerosis	8.74e-05	0.00274	CbGpPWpGaD
Ranitidine—HRH2—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	8.63e-05	0.00271	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	8.59e-05	0.0027	CbGpPWpGaD
Ranitidine—SLC22A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	8.57e-05	0.00269	CbGpPWpGaD
Ranitidine—SLC22A1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	8.42e-05	0.00265	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—GPR65—multiple sclerosis	8.38e-05	0.00263	CbGpPWpGaD
Ranitidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	8.21e-05	0.00258	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—CNR1—multiple sclerosis	8.06e-05	0.00253	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	8.03e-05	0.00252	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—RGS1—multiple sclerosis	8.02e-05	0.00252	CbGpPWpGaD
Ranitidine—SLC22A8—Transmembrane transport of small molecules—AQP4—multiple sclerosis	7.92e-05	0.00249	CbGpPWpGaD
Ranitidine—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	7.88e-05	0.00248	CbGpPWpGaD
Ranitidine—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	7.88e-05	0.00248	CbGpPWpGaD
Ranitidine—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	7.77e-05	0.00244	CbGpPWpGaD
Ranitidine—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	7.77e-05	0.00244	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—CD86—multiple sclerosis	7.74e-05	0.00243	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—CCR1—multiple sclerosis	7.66e-05	0.00241	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—CXCL13—multiple sclerosis	7.66e-05	0.00241	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—GPR65—multiple sclerosis	7.61e-05	0.00239	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—IL10—multiple sclerosis	7.59e-05	0.00238	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	7.59e-05	0.00238	CbGpPWpGaD
Ranitidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	7.39e-05	0.00232	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—IL4—multiple sclerosis	7.38e-05	0.00232	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—LINGO1—multiple sclerosis	7.36e-05	0.00231	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—CXCL10—multiple sclerosis	7.26e-05	0.00228	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	7.22e-05	0.00227	CbGpPWpGaD
Ranitidine—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.18e-05	0.00226	CbGpPWpGaD
Ranitidine—SLC22A8—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7e-05	0.0022	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—CXCL13—multiple sclerosis	6.96e-05	0.00219	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—CCR1—multiple sclerosis	6.96e-05	0.00219	CbGpPWpGaD
Ranitidine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.85e-05	0.00215	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—FAS—multiple sclerosis	6.8e-05	0.00214	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	6.76e-05	0.00212	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	6.69e-05	0.0021	CbGpPWpGaD
Ranitidine—SLC22A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.5e-05	0.00204	CbGpPWpGaD
Ranitidine—SLC22A1—Neuronal System—BCHE—multiple sclerosis	6.45e-05	0.00203	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—TAGAP—multiple sclerosis	6.38e-05	0.002	CbGpPWpGaD
Ranitidine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.3e-05	0.00198	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—CCL5—multiple sclerosis	6.25e-05	0.00196	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	6.11e-05	0.00192	CbGpPWpGaD
Ranitidine—HRH2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	5.78e-05	0.00182	CbGpPWpGaD
Ranitidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	5.65e-05	0.00178	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—CD80—multiple sclerosis	5.64e-05	0.00177	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—CCR5—multiple sclerosis	5.63e-05	0.00177	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—S1PR1—multiple sclerosis	5.57e-05	0.00175	CbGpPWpGaD
Ranitidine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.55e-05	0.00174	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	5.49e-05	0.00172	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—GPC5—multiple sclerosis	5.42e-05	0.0017	CbGpPWpGaD
Ranitidine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.34e-05	0.00168	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—SRM—multiple sclerosis	5.3e-05	0.00166	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—PTGER4—multiple sclerosis	5.25e-05	0.00165	CbGpPWpGaD
Ranitidine—SLC22A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.14e-05	0.00161	CbGpPWpGaD
Ranitidine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.11e-05	0.0016	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—CXCR3—multiple sclerosis	5.07e-05	0.00159	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.03e-05	0.00158	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.03e-05	0.00158	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.02e-05	0.00158	CbGpPWpGaD
Ranitidine—SLC22A8—SLC-mediated transmembrane transport—ALB—multiple sclerosis	4.96e-05	0.00156	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—CCL3—multiple sclerosis	4.96e-05	0.00156	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—CCR2—multiple sclerosis	4.94e-05	0.00155	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	4.9e-05	0.00154	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	4.89e-05	0.00153	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	4.88e-05	0.00153	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—PTGER4—multiple sclerosis	4.77e-05	0.0015	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—RGS1—multiple sclerosis	4.74e-05	0.00149	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—CXCR3—multiple sclerosis	4.61e-05	0.00145	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—CNR1—multiple sclerosis	4.56e-05	0.00143	CbGpPWpGaD
Ranitidine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	4.54e-05	0.00143	CbGpPWpGaD
Ranitidine—SLC22A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.54e-05	0.00143	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—GPR65—multiple sclerosis	4.49e-05	0.00141	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—CCR2—multiple sclerosis	4.48e-05	0.00141	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	4.46e-05	0.0014	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—POMC—multiple sclerosis	4.4e-05	0.00138	CbGpPWpGaD
Ranitidine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.33e-05	0.00136	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—CCL2—multiple sclerosis	4.3e-05	0.00135	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—CNR1—multiple sclerosis	4.14e-05	0.0013	CbGpPWpGaD
Ranitidine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.12e-05	0.00129	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—SRM—multiple sclerosis	4.12e-05	0.00129	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CXCL13—multiple sclerosis	4.11e-05	0.00129	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CCR1—multiple sclerosis	4.11e-05	0.00129	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—CXCL10—multiple sclerosis	4.1e-05	0.00129	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	3.98e-05	0.00125	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—IL2—multiple sclerosis	3.96e-05	0.00125	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	3.92e-05	0.00123	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.92e-05	0.00123	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.92e-05	0.00123	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	3.81e-05	0.0012	CbGpPWpGaD
Ranitidine—CYP3A5—Biological oxidations—POMC—multiple sclerosis	3.81e-05	0.0012	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.81e-05	0.0012	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	3.81e-05	0.0012	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—CYP24A1—multiple sclerosis	3.73e-05	0.00117	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—CYP27B1—multiple sclerosis	3.73e-05	0.00117	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	3.73e-05	0.00117	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—CXCL10—multiple sclerosis	3.73e-05	0.00117	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	3.55e-05	0.00112	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	3.55e-05	0.00112	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—CCL5—multiple sclerosis	3.53e-05	0.00111	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—GPC5—multiple sclerosis	3.41e-05	0.00107	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	3.36e-05	0.00105	CbGpPWpGaD
Ranitidine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.34e-05	0.00105	CbGpPWpGaD
Ranitidine—SLC22A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.22e-05	0.00101	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—CCL5—multiple sclerosis	3.21e-05	0.00101	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—SRM—multiple sclerosis	3.18e-05	0.001	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—CCR5—multiple sclerosis	3.18e-05	0.000999	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—IL2RA—multiple sclerosis	3.14e-05	0.000985	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—SRM—multiple sclerosis	3.11e-05	0.000976	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	3.09e-05	0.000972	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.01e-05	0.000946	CbGpPWpGaD
Ranitidine—CYP2C19—Biological oxidations—POMC—multiple sclerosis	2.95e-05	0.000926	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CCL3—multiple sclerosis	2.93e-05	0.00092	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—SRM—multiple sclerosis	2.93e-05	0.000919	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	2.9e-05	0.000911	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	2.9e-05	0.000911	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—CCR5—multiple sclerosis	2.89e-05	0.000908	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—TNF—multiple sclerosis	2.89e-05	0.000907	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—IL2RA—multiple sclerosis	2.85e-05	0.000894	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—RRM1—multiple sclerosis	2.83e-05	0.000889	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PTGER4—multiple sclerosis	2.82e-05	0.000886	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PGR—multiple sclerosis	2.78e-05	0.000872	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CXCR3—multiple sclerosis	2.72e-05	0.000855	CbGpPWpGaD
Ranitidine—CYP2D6—Biological oxidations—POMC—multiple sclerosis	2.71e-05	0.000852	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CD28—multiple sclerosis	2.7e-05	0.000847	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.66e-05	0.000836	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—GPC5—multiple sclerosis	2.65e-05	0.000833	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CCR2—multiple sclerosis	2.65e-05	0.000832	CbGpPWpGaD
Ranitidine—SLC22A8—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.52e-05	0.000792	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—POMC—multiple sclerosis	2.49e-05	0.000781	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—SRM—multiple sclerosis	2.48e-05	0.000779	CbGpPWpGaD
Ranitidine—SLC22A1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.46e-05	0.000773	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CNR1—multiple sclerosis	2.44e-05	0.000768	CbGpPWpGaD
Ranitidine—CYP1A2—Biological oxidations—POMC—multiple sclerosis	2.3e-05	0.000722	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—POMC—multiple sclerosis	2.26e-05	0.000709	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	2.24e-05	0.000704	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	2.24e-05	0.000704	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—CCL2—multiple sclerosis	2.21e-05	0.000694	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CXCL10—multiple sclerosis	2.2e-05	0.000691	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—RRM1—multiple sclerosis	2.2e-05	0.00069	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.19e-05	0.000688	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CYP24A1—multiple sclerosis	2.19e-05	0.000687	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CYP27B1—multiple sclerosis	2.19e-05	0.000687	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	2.06e-05	0.000648	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	2.06e-05	0.000648	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GPC5—multiple sclerosis	2.05e-05	0.000644	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—TYK2—multiple sclerosis	2.01e-05	0.00063	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GPC5—multiple sclerosis	2e-05	0.000629	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CD86—multiple sclerosis	1.92e-05	0.000605	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—SRM—multiple sclerosis	1.91e-05	0.000601	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CCL5—multiple sclerosis	1.89e-05	0.000595	CbGpPWpGaD
Ranitidine—SLC22A1—Neuronal System—MAPK1—multiple sclerosis	1.89e-05	0.000592	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GPC5—multiple sclerosis	1.89e-05	0.000592	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—IL2—multiple sclerosis	1.84e-05	0.000577	CbGpPWpGaD
Ranitidine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.77e-05	0.000557	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—SPP1—multiple sclerosis	1.75e-05	0.000551	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	1.75e-05	0.000549	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	1.75e-05	0.000549	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.71e-05	0.000536	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CCR5—multiple sclerosis	1.71e-05	0.000536	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.7e-05	0.000534	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—IL2RA—multiple sclerosis	1.68e-05	0.000528	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—IL2—multiple sclerosis	1.67e-05	0.000524	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—RRM1—multiple sclerosis	1.66e-05	0.000521	CbGpPWpGaD
Ranitidine—SLC22A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.63e-05	0.000514	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—BCHE—multiple sclerosis	1.62e-05	0.00051	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GPC5—multiple sclerosis	1.6e-05	0.000502	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.56e-05	0.000491	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—APOE—multiple sclerosis	1.55e-05	0.000488	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.53e-05	0.000481	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.53e-05	0.000479	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.5e-05	0.00047	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.43e-05	0.000448	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CD80—multiple sclerosis	1.4e-05	0.000441	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.35e-05	0.000424	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.35e-05	0.000424	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—POMC—multiple sclerosis	1.33e-05	0.000419	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.32e-05	0.000416	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.32e-05	0.000414	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CCL2—multiple sclerosis	1.31e-05	0.00041	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—MAPK1—multiple sclerosis	1.28e-05	0.000401	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—BCHE—multiple sclerosis	1.26e-05	0.000397	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.23e-05	0.000387	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—TYK2—multiple sclerosis	1.18e-05	0.000372	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.13e-05	0.000356	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.03e-05	0.000324	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.03e-05	0.000323	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.02e-05	0.000321	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—IL2—multiple sclerosis	9.86e-06	0.00031	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—IL6—multiple sclerosis	9.81e-06	0.000308	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—APOE—multiple sclerosis	9.77e-06	0.000307	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—BCHE—multiple sclerosis	9.76e-06	0.000307	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.58e-06	0.000301	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—BCHE—multiple sclerosis	9.52e-06	0.000299	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MMP9—multiple sclerosis	9.33e-06	0.000293	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—BCHE—multiple sclerosis	8.97e-06	0.000282	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.82e-06	0.000277	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—POMC—multiple sclerosis	8.4e-06	0.000264	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—STAT3—multiple sclerosis	8.3e-06	0.000261	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.04e-06	0.000253	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MYC—multiple sclerosis	7.71e-06	0.000242	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—TGFB1—multiple sclerosis	7.69e-06	0.000242	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—ALB—multiple sclerosis	7.66e-06	0.000241	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—BCHE—multiple sclerosis	7.6e-06	0.000239	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—APOE—multiple sclerosis	7.59e-06	0.000239	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MAPK1—multiple sclerosis	7.54e-06	0.000237	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—POMC—multiple sclerosis	6.52e-06	0.000205	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—ALB—multiple sclerosis	5.95e-06	0.000187	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—APOE—multiple sclerosis	5.87e-06	0.000184	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—BCHE—multiple sclerosis	5.87e-06	0.000184	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—IL6—multiple sclerosis	5.8e-06	0.000182	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—APOE—multiple sclerosis	5.73e-06	0.00018	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—APOE—multiple sclerosis	5.4e-06	0.00017	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—POMC—multiple sclerosis	5.04e-06	0.000158	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—POMC—multiple sclerosis	4.92e-06	0.000155	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—POMC—multiple sclerosis	4.64e-06	0.000146	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—ALB—multiple sclerosis	4.6e-06	0.000144	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—APOE—multiple sclerosis	4.57e-06	0.000144	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—ALB—multiple sclerosis	4.49e-06	0.000141	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ALB—multiple sclerosis	4.23e-06	0.000133	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—POMC—multiple sclerosis	3.93e-06	0.000123	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ALB—multiple sclerosis	3.58e-06	0.000113	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—APOE—multiple sclerosis	3.53e-06	0.000111	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—POMC—multiple sclerosis	3.03e-06	9.53e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ALB—multiple sclerosis	2.76e-06	8.69e-05	CbGpPWpGaD
